{"ticker": {"uuid": "0304e234-28f6-4293-a787-f01139a1efb4", "symbol": "2096", "name": "Simcere Pharmaceutical Group Limited", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "[HKEX Correction] Simcere Pharmaceutical (02096.HK) received an increase of 100,000 ordinary shares held by Peng Suqin, valued at approximately HK$1.048 million.", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNVHA4UFgtR19KYzJsVlZOZkRYX0lkV3VvMXRlem9KQi1pWXNpX0s4WklLRExyeHFJVF9pNDFuUDBva21iemlXWEtBcjZNTmtMaUtnbGJVNjhaSzdFN1gtaS1tcmU2QUJsSEtPdnFGTHNLdEFORUF5eXZGeFZKMUR4bXVMS0JMNEVQX3hQcExvUmZUYzUtSkNjNDdldU1sbXFRcDhKc1RxMHBVdWNWZ0lJY1F3?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-17T10:33:59+00:00", "published_display": "17 Jul 2026 10:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Stock Market Alert | Simcere Pharmaceutical (02096) Surges Over 6% Intraday Following Global Drug Discovery and Development Collaboration Agreement with U.S.-based Schr\u00f6dinger, Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQZEZmVFlvLS03VHByalhrTHhZWXFjbnVjVmpLQ2d5NkhxYVkwWTY5ZEx1ZkZFRzFSQnZRWlNTZ3gzakhTYTJ0dTg0dUNXeDZwQjJRM3dMa0hsdGlzc0FRcHVtckVDTk9DSFhRLWVDclgtVWVSd01yUHZaU05HUlZoSHpWcEhsaEZsSERPQzFCNlJ3cEk1VEdlbG9BY1E5b3BxbzloaUU3RHU0U1MteUJv?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-15T10:20:36+00:00", "published_display": "15 Jul 2026 10:20", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Simcere Pharmaceutical Group (SEHK:2096) Stock Could Be 70% Below Fair Value After Stanford IPF Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPV0VBdGNiSVJmY01UeG4wTEhhWVZxNXM3WVplWTJOQm5BYW5zY05Jbm5ndnhCQndjbDZBRkpzVjVaODJSNzdyYTE3RmFfTVhsSEZnX0otMENtTDJSMEZYbDZpUlpFR3ZJdVBmOTRwbzk0bmpSdGVVWU9jMUNyUG5IRFpsbm9NNUVmNHQ0RDQ3cjc4ZUljRUNEQlJjbEg1MzJyUWVwVXhWVEFpWVBFUDdIQko1SXo2TGpILTQ1WFVJMmRGWWY5VGxLYzdHSjZjSUtNTFNjTWhkSDluREFtb3hBZkZwaTRPdnI2UlktM3NOeWdaR3hFQzZWYU9B0gH_AUFVX3lxTE9qZGtwd1RINXF0NktDSS1ZSzlXb1ZmZTFvUUw4cDdPRXRYUFc4RmxERi05aG03cV9WT0RmcVJBN3dSc3A1cnRya0JUb3pwX1NVVFpac0dqRGRZSHNsSkYxMTNpZV9vU2pPcVBGT0dVMV9ocXpVcTVhczBoaEJmMVllY3BnRGpPMXJVVGZWWm56emZFWGtVdXFOY3gyd1g1aW5DLXdsUWxnY1JkckNLenM4MEpTODVmay1jSTBmZlJnTFdPVlFVTDNPQUhva0k4ajdzQUV0V3VOZGRJSGYzdUlWelF3MnlTWGhWODB5YVJQallxdUZfRXhLVUl5emdPdw?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BRIEF: Simcere Pharma profit surges in 2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMickFVX3lxTE9COGRSMFdsNlktcVBtRU1PdnRPT1RLQ0NidW9pbVRVZjFKNFpXdEFCREV0WEY1cU1tbkJTTmVpZ2dzSVhLVGU5R01RTkdPWGVKTU5JS1lPSHhwalM5bHlTbEpxdmtMMkVpMDQ3WWVHRHJndw?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boehringer Ingelheim in deal with China's Simcere Pharma to license IBD drug candidate", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPU1RUQVdCc2lDZDVqcGNIeTRsRWt0ZnlOQ0NZNF95M00xcHVPRW14QnM2clhJOTJtVXM2ZVpIWk5mNEJINmV0NXpOY3dwSWRxSHh4Zy1FMmgtbTF5NjZEYWVXU3F4cS1PV09xZ29qcXI2VzFMbWZEaThwRFJBUjNLNjRTYThOaDMxdDc4ZkIzT25sbHo2SDgtazNJdFdCdzllc3pCMGhNaHlYS2Q1N05jam92TDdzelVJWk5qODAzMHNDODhZTmRQUmxJRlFoQVJQdDNKcVVEY2xRdUhFNjUtT3hJQThpdw?oc=5", "source_name": "Reuters", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s Simcere Pharmaceutical Advances At Home After Exit From NYSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNM1l1OUtzTmhKb0Nzc3E0WFNvZ3Bad0hxSDQ5dWN2ekwwT1lpWXJZdUZTWXlsYmp2RHk4eEhxeG01Z2JpbkpRNWFEbmhHb1BWN0hteDZ2cTJFRExTY2NiR0N2YnpCSnJ4aVlUc1hDX0NVTDFsQW9GZVBYRS1ma3FZSTFYRVJqTXc1N3FtWURzbzVJT0dyZWFOZV9ncFNaVGt5ZmY0N1hWSVZvbjFxMEgtbjJZYTFGSlhxUW5XT0Z5WlBSUQ?oc=5", "source_name": "Forbes", "published_at": "2021-09-12T07:00:00+00:00", "published_display": "12 Sep 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kazia Licenses Rights to Paxalisib in Greater China to Simcere, a Leading Chinese Pharmaceutical Company", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxOVTdPdXBjUnNiUktmS1pGcDNMUnB1dk9aUlRXRmU1bGJOUDVoa1JvWXhjUkJSWFRPcmg2S1lUM2RDb08yX2hDTlZFMXBSc0lMemhNT0JFUlpVb0dQeVFDaVBWWjVaaTRVaklEampjZ3BFVWd3b0VYbmNiQlpONGo4YTNUTlRZUEl1N3AzTnBVaGRrTmd0ekF5MFVOZ1lDNi0yOWRKQm5MazQzSkpMTFpRNzkyQzJPQ3hBV013RE9id2tqTFFkcV9HYXcyS2MtNXN4NF9Ra3VvbTdRWmYySlJjMzlKTW0weEF2cVRXbFV2Mlo?oc=5", "source_name": "PR Newswire", "published_at": "2021-03-29T07:00:00+00:00", "published_display": "29 Mar 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SIMCERE PHARMACEUTICAL GROUP LTD. (2096)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQX2RZXzMwaXZ4YUdtQVp5emV4N21rZFZqN2hkVVh3OWNkUHUtRGd0ckN5ZklUa3dGNHc4SF90bGJoNmI2UlBtTUVKV2o1REVMRXBIOVJXMUJuNkpJckxRdVdHSWw5VzBhcndBOHdzb2dWaWNaTU9DQ05UbUJkOWhJWUxDQmdlMV93dm1VSGZWZExDazhmSk1VdHFack1vdw?oc=5", "source_name": "hkex.com.hk", "published_at": "2020-10-27T07:00:00+00:00", "published_display": "27 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "[HKEX Correction] Simcere Pharmaceutical (02096.HK) received an increase of 100,000 ordinary shares held by Peng Suqin, valued at approximately HK$1.048 million.", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNVHA4UFgtR19KYzJsVlZOZkRYX0lkV3VvMXRlem9KQi1pWXNpX0s4WklLRExyeHFJVF9pNDFuUDBva21iemlXWEtBcjZNTmtMaUtnbGJVNjhaSzdFN1gtaS1tcmU2QUJsSEtPdnFGTHNLdEFORUF5eXZGeFZKMUR4bXVMS0JMNEVQX3hQcExvUmZUYzUtSkNjNDdldU1sbXFRcDhKc1RxMHBVdWNWZ0lJY1F3?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-17T10:33:59+00:00", "published_display": "17 Jul 2026 10:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Stock Market Alert | Simcere Pharmaceutical (02096) Surges Over 6% Intraday Following Global Drug Discovery and Development Collaboration Agreement with U.S.-based Schr\u00f6dinger, Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQZEZmVFlvLS03VHByalhrTHhZWXFjbnVjVmpLQ2d5NkhxYVkwWTY5ZEx1ZkZFRzFSQnZRWlNTZ3gzakhTYTJ0dTg0dUNXeDZwQjJRM3dMa0hsdGlzc0FRcHVtckVDTk9DSFhRLWVDclgtVWVSd01yUHZaU05HUlZoSHpWcEhsaEZsSERPQzFCNlJ3cEk1VEdlbG9BY1E5b3BxbzloaUU3RHU0U1MteUJv?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-15T10:20:36+00:00", "published_display": "15 Jul 2026 10:20", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Simcere Pharmaceutical Group (SEHK:2096) Stock Could Be 70% Below Fair Value After Stanford IPF Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPV0VBdGNiSVJmY01UeG4wTEhhWVZxNXM3WVplWTJOQm5BYW5zY05Jbm5ndnhCQndjbDZBRkpzVjVaODJSNzdyYTE3RmFfTVhsSEZnX0otMENtTDJSMEZYbDZpUlpFR3ZJdVBmOTRwbzk0bmpSdGVVWU9jMUNyUG5IRFpsbm9NNUVmNHQ0RDQ3cjc4ZUljRUNEQlJjbEg1MzJyUWVwVXhWVEFpWVBFUDdIQko1SXo2TGpILTQ1WFVJMmRGWWY5VGxLYzdHSjZjSUtNTFNjTWhkSDluREFtb3hBZkZwaTRPdnI2UlktM3NOeWdaR3hFQzZWYU9B0gH_AUFVX3lxTE9qZGtwd1RINXF0NktDSS1ZSzlXb1ZmZTFvUUw4cDdPRXRYUFc4RmxERi05aG03cV9WT0RmcVJBN3dSc3A1cnRya0JUb3pwX1NVVFpac0dqRGRZSHNsSkYxMTNpZV9vU2pPcVBGT0dVMV9ocXpVcTVhczBoaEJmMVllY3BnRGpPMXJVVGZWWm56emZFWGtVdXFOY3gyd1g1aW5DLXdsUWxnY1JkckNLenM4MEpTODVmay1jSTBmZlJnTFdPVlFVTDNPQUhva0k4ajdzQUV0V3VOZGRJSGYzdUlWelF3MnlTWGhWODB5YVJQallxdUZfRXhLVUl5emdPdw?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BRIEF: Simcere Pharma profit surges in 2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMickFVX3lxTE9COGRSMFdsNlktcVBtRU1PdnRPT1RLQ0NidW9pbVRVZjFKNFpXdEFCREV0WEY1cU1tbkJTTmVpZ2dzSVhLVGU5R01RTkdPWGVKTU5JS1lPSHhwalM5bHlTbEpxdmtMMkVpMDQ3WWVHRHJndw?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boehringer Ingelheim in deal with China's Simcere Pharma to license IBD drug candidate", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPU1RUQVdCc2lDZDVqcGNIeTRsRWt0ZnlOQ0NZNF95M00xcHVPRW14QnM2clhJOTJtVXM2ZVpIWk5mNEJINmV0NXpOY3dwSWRxSHh4Zy1FMmgtbTF5NjZEYWVXU3F4cS1PV09xZ29qcXI2VzFMbWZEaThwRFJBUjNLNjRTYThOaDMxdDc4ZkIzT25sbHo2SDgtazNJdFdCdzllc3pCMGhNaHlYS2Q1N05jam92TDdzelVJWk5qODAzMHNDODhZTmRQUmxJRlFoQVJQdDNKcVVEY2xRdUhFNjUtT3hJQThpdw?oc=5", "source_name": "Reuters", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s Simcere Pharmaceutical Advances At Home After Exit From NYSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNM1l1OUtzTmhKb0Nzc3E0WFNvZ3Bad0hxSDQ5dWN2ekwwT1lpWXJZdUZTWXlsYmp2RHk4eEhxeG01Z2JpbkpRNWFEbmhHb1BWN0hteDZ2cTJFRExTY2NiR0N2YnpCSnJ4aVlUc1hDX0NVTDFsQW9GZVBYRS1ma3FZSTFYRVJqTXc1N3FtWURzbzVJT0dyZWFOZV9ncFNaVGt5ZmY0N1hWSVZvbjFxMEgtbjJZYTFGSlhxUW5XT0Z5WlBSUQ?oc=5", "source_name": "Forbes", "published_at": "2021-09-12T07:00:00+00:00", "published_display": "12 Sep 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kazia Licenses Rights to Paxalisib in Greater China to Simcere, a Leading Chinese Pharmaceutical Company", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxOVTdPdXBjUnNiUktmS1pGcDNMUnB1dk9aUlRXRmU1bGJOUDVoa1JvWXhjUkJSWFRPcmg2S1lUM2RDb08yX2hDTlZFMXBSc0lMemhNT0JFUlpVb0dQeVFDaVBWWjVaaTRVaklEampjZ3BFVWd3b0VYbmNiQlpONGo4YTNUTlRZUEl1N3AzTnBVaGRrTmd0ekF5MFVOZ1lDNi0yOWRKQm5MazQzSkpMTFpRNzkyQzJPQ3hBV013RE9id2tqTFFkcV9HYXcyS2MtNXN4NF9Ra3VvbTdRWmYySlJjMzlKTW0weEF2cVRXbFV2Mlo?oc=5", "source_name": "PR Newswire", "published_at": "2021-03-29T07:00:00+00:00", "published_display": "29 Mar 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SIMCERE PHARMACEUTICAL GROUP LTD. (2096)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQX2RZXzMwaXZ4YUdtQVp5emV4N21rZFZqN2hkVVh3OWNkUHUtRGd0ckN5ZklUa3dGNHc4SF90bGJoNmI2UlBtTUVKV2o1REVMRXBIOVJXMUJuNkpJckxRdVdHSWw5VzBhcndBOHdzb2dWaWNaTU9DQ05UbUJkOWhJWUxDQmdlMV93dm1VSGZWZExDazhmSk1VdHFack1vdw?oc=5", "source_name": "hkex.com.hk", "published_at": "2020-10-27T07:00:00+00:00", "published_display": "27 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 61, "total_relevant": 8, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 6, "score": 56, "total": 8, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 1.45, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 12.09, "latest_week": "2026-07-10", "one_week_move": 5.4, "four_week_move": 22.2, "twelve_week_move": -10.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.577051, "market_dynamics_buy_signal": false, "relative_strength": 4.765236, "fair_value_gap": 41.2, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 47.5678, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+5.4% over one week, +22.2% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "\u5bcc\u9014\u725b\u725b", "count": 2}, {"label": "simplywall.st", "count": 1}, {"label": "thebambooworks.com", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "Forbes", "count": 1}, {"label": "PR Newswire", "count": 1}, {"label": "hkex.com.hk", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 8}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Deals and strategy", "count": 2}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "8", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+5.4% over one week, +22.2% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "[HKEX Correction] Simcere Pharmaceutical (02096.HK) received an increase of 100,000 ordinary shares held by Peng Suqin, valued at approximately HK$1.048 million."}], "updated_at": "2026-07-18T07:47:56.851418+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}